Aspen admits 1,800% U.K. price hike was wrong—and it'll pay $10M in penance

Aspen admits 1,800% U.K. price hike was wrong—and it'll pay $10M in penance

Source: 
Fierce Pharma
snippet: 

In 2016, Aspen agreed to pay potential rivals Amilco and Tiofarma to stay out of the U.K. market for fludrocortisone acetate tablets, which treat Addison’s disease, CMA said Thursday.